Professional Documents
Culture Documents
IN
Narration Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Trailing Best Case Worst Case
Sales 5,727.90 8,019.49 11,130.57 16,080.36 27,392.01 28,487.03 31,578.44 26,489.46 29,065.91 32,837.50 33,160.10 37,098.49 33,272.48
Expenses 3,768.00 4,816.28 6,346.38 9,367.19 19,705.96 20,425.10 21,489.17 20,884.57 22,709.79 25,882.80 25,354.16 28,365.45 26,152.30
Operating Profit 1,959.90 3,203.21 4,784.19 6,713.17 7,686.05 8,061.93 10,089.27 5,604.89 6,356.12 6,954.70 7,805.94 8,733.04 7,120.17
Other Income 354.78 471.51 -89.97 -1,678.58 490.56 69.47 623.15 -108.50 -237.42 410.40 -2,778.94 - -
Depreciation 204.85 291.16 336.17 409.23 1,194.72 1,037.53 1,264.75 1,499.84 1,753.25 2,052.78 2,101.84 2,101.84 2,101.84
Interest 73.88 28.20 43.16 44.19 578.99 523.24 399.80 517.57 555.25 302.73 163.11 163.11 163.11
Profit before tax 2,035.95 3,355.36 4,314.89 4,581.17 6,402.90 6,570.63 9,047.87 3,478.98 3,810.20 5,009.59 2,762.05 6,468.09 4,855.22
Tax 128.58 313.19 845.55 702.17 914.69 913.77 1,211.57 911.04 600.88 822.80 831.02 30% 30%
Net profit 1,816.06 2,656.69 2,983.06 3,141.47 4,539.38 4,545.71 6,964.37 2,095.70 2,665.42 3,764.93 2,409.51 4,522.03 3,394.43
EPS 8.77 12.83 14.40 15.17 21.92 18.89 29.03 8.73 11.11 15.69 10.04 18.85 14.15
Price to earning 25.23 22.22 28.43 37.89 46.72 43.41 23.71 56.68 43.10 22.45 61.17 61.17 37.36
Price 221.25 284.98 409.48 574.75 1,023.90 820.00 688.15 495.10 478.85 352.30 614.25 1,152.79 528.61
RATIOS:
Dividend Payout 19.96% 16.57% 8.68% 9.89% 13.69% 5.29% 12.06% 22.90% 24.75% 25.49%
OPM 34.22% 39.94% 42.98% 41.75% 28.06% 28.30% 31.95% 21.16% 21.87% 21.18% 23.54%
Narration Sep-18 Dec-18 Mar-19 Jun-19 Sep-19 Dec-19 Mar-20 Jun-20 Sep-20 Dec-20
Sales 6,937.63 7,740.19 7,163.92 8,374.36 8,123.35 8,154.85 8,184.94 7,585.25 8,553.13 8,836.78
Expenses 5,406.42 5,587.30 6,147.13 6,378.75 6,333.61 6,313.45 6,821.93 5,741.74 6,359.85 6,430.64
Operating Profit 1,531.21 2,152.89 1,016.79 1,995.61 1,789.74 1,841.40 1,363.01 1,843.51 2,193.28 2,406.14
Other Income -863.23 193.06 281.53 213.02 200.85 119.88 -158.41 -3,479.54 544.06 314.95
Depreciation 426.51 471.05 454.05 457.13 473.28 546.99 575.38 495.92 498.60 531.94
Interest 129.53 144.79 150.03 104.06 83.93 62.96 51.78 51.95 33.28 26.10
Profit before tax 111.94 1,730.11 694.24 1,647.44 1,433.38 1,351.33 577.44 -2,183.90 2,205.46 2,163.05
Tax 269.69 270.92 -28.81 146.06 266.03 327.62 83.09 245.91 257.08 244.94
Net profit -269.60 1,241.85 635.88 1,387.48 1,064.09 913.52 399.84 -1,655.60 1,812.79 1,852.48
OPM 22% 28% 14% 24% 22% 23% 17% 24% 26% 27%
SUN PHARMACEUTICALS INDUSTRIES LTD SCREENER.IN
Narration Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20
Equity Share Capital 103.56 103.56 103.56 207.12 207.12 240.66 239.93 239.93 239.93 239.93
Reserves 9,379.76 12,132.22 14,886.17 18,317.83 25,382.59 32,741.15 36,399.74 38,074.18 41,169.13 45,024.52
Borrowings 425.58 320.73 259.71 2,560.86 8,996.11 8,496.76 9,831.77 10,385.27 10,514.36 8,314.88
Other Liabilities 2,329.41 3,762.29 5,127.88 8,009.34 14,137.37 13,948.93 14,624.01 15,598.01 12,666.11 14,614.99
Total 12,238.31 16,318.80 20,377.32 29,095.15 48,723.19 55,427.50 61,095.45 64,297.39 64,589.53 68,194.32
Net Block 3,293.35 3,951.35 5,647.47 6,817.28 12,682.47 15,872.25 17,675.17 18,852.65 21,836.54 22,846.91
Capital Work in Progress 235.46 344.65 562.61 841.54 2,038.61 2,175.45 2,801.38 2,465.16 1,411.15 1,220.34
Investments 2,229.76 2,212.87 2,411.57 2,786.02 2,716.30 1,829.88 1,191.88 7,142.87 7,902.53 10,143.11
Other Assets 6,479.74 9,809.93 11,755.67 18,650.31 31,285.81 35,549.92 39,427.02 35,836.71 33,439.31 33,983.96
Total 12,238.31 16,318.80 20,377.32 29,095.15 48,723.19 55,427.50 61,095.45 64,297.39 64,589.53 68,194.32
Working Capital 4,150.33 6,047.64 6,627.79 10,640.97 17,148.44 21,600.99 24,803.01 20,238.70 20,773.20 19,368.97
Debtors 1,104.87 2,078.74 2,412.23 2,200.42 5,106.13 6,775.66 7,202.61 7,815.28 8,884.20 9,421.24
Inventory 1,489.48 2,086.98 2,577.76 3,123.01 5,667.99 6,422.54 6,832.81 6,880.69 7,885.98 7,874.99
Debtor Days 70.41 94.61 79.10 49.95 68.04 86.82 83.25 107.69 111.56 104.72
Inventory Turnover 3.85 3.84 4.32 5.15 4.83 4.44 4.62 3.85 3.69 4.17
Narration Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20
Cash from Operating Activity 2,281.13 2,234.46 3,356.58 3,959.20 5,615.74 6,685.86 7,082.21 3,907.15 2,196.45 6,554.77
Cash from Investing Activity -1,300.32 -747.89 -2,375.15 -2,176.18 -1,502.35 -3,949.13 -4,186.15 -3,103.80 -310.08 -2,225.32
Cash from Financing Activity -804.19 -544.39 -664.99 506.57 -1,186.53 -1,888.53 -2,285.39 -1,539.26 -2,730.52 -5,715.14
Net Cash Flow 176.62 942.18 316.44 2,289.59 2,926.86 848.20 610.67 -735.91 -844.15 -1,385.69
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.
TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: screener.feedback@dalal-street.in
s… do ANYTHING.
@dalal-street.in
COMPANY NAME SUN PHARMACEUTICALS INDUSTRIES LTD
LATEST VERSION 2.10 PLEAS
CURRENT VERSION 2.10
META
Number of shares 239.93
Face Value 1.00
Current Price 614.25
Market Capitalization 147,379.15
Quarters
Report Date Sep-18 Dec-18 Mar-19 Jun-19
Sales 6,937.63 7,740.19 7,163.92 8,374.36
Expenses 5,406.42 5,587.30 6,147.13 6,378.75
Other Income -863.23 193.06 281.53 213.02
Depreciation 426.51 471.05 454.05 457.13
Interest 129.53 144.79 150.03 104.06
Profit before tax 111.94 1,730.11 694.24 1,647.44
Tax 269.69 270.92 -28.81 146.06
Net profit -269.60 1,241.85 635.88 1,387.48
Operating Profit 1,531.21 2,152.89 1,016.79 1,995.61
BALANCE SHEET
Report Date Mar-11 Mar-12 Mar-13 Mar-14
Equity Share Capital 103.56 103.56 103.56 207.12
Reserves 9,379.76 12,132.22 14,886.17 18,317.83
Borrowings 425.58 320.73 259.71 2,560.86
Other Liabilities 2,329.41 3,762.29 5,127.88 8,009.34
Total 12,238.31 16,318.80 20,377.32 29,095.15
Net Block 3,293.35 3,951.35 5,647.47 6,817.28
Capital Work in Progress 235.46 344.65 562.61 841.54
Investments 2,229.76 2,212.87 2,411.57 2,786.02
Other Assets 6,479.74 9,809.93 11,755.67 18,650.31
Total 12,238.31 16,318.80 20,377.32 29,095.15
Receivables 1,104.87 2,078.74 2,412.23 2,200.42
Inventory 1,489.48 2,086.98 2,577.76 3,123.01
Cash & Bank 2,204.63 3,367.19 4,058.71 7,590.15
No. of Equity Shares ### ### ### ###
New Bonus Shares ###
Face value 1.00 1.00 1.00 1.00
CASH FLOW:
Report Date Mar-11 Mar-12 Mar-13 Mar-14
Cash from Operating Activity 2,281.13 2,234.46 3,356.58 3,959.20
Cash from Investing Activity -1,300.32 -747.89 -2,375.15 -2,176.18
Cash from Financing Activity -804.19 -544.39 -664.99 506.57
Net Cash Flow 176.62 942.18 316.44 2,289.59
DERIVED:
Adjusted Equity Shares in Cr 207.10 207.10 207.10 207.12
PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET